Abstract
The risk of having a child with a monogenic disease cannot be excluded for any family. However, in a population of couples suffering from infertility, the frequency of heterozygous carriage of a monogenic pathology is higher than in a population with normal fertility. For example, a number of studies have proven the assotiation between male infertility and the carriage of pathogenic variants in the CFTR gene associated with cystic fibrosis. The purpose of the study was, based on a clinical case, to demonstrate the importance of testing for carriage of pathogenic genetic variants in the CFTR gene in married couples seeking assisted reproductive technologies (ART). For the analysis, medical documentation of the proband child and his parents were used. In a couple with confirmed male factor infertility, as a result of in vitro fertilization (IVF), a child was born who was diagnosed with cystic fibrosis at the age of 8 months (despite a negative result of neonatal screening). The child's father's sister also has cystic fibrosis, but the results of her genetic testing were not available. Preconception examination did not reveal common pathogenic variants in the CFTR gene in the father of the child; this study was not carried out on the mother of the child. The child’s diagnosis was confirmed by sequencing of the CFTR gene (2 pathogenic genetic variants were found in the compound heterozygous state: G194R and F508del). Subsequently, the mother was confirmed to be a carrier of the most common pathogenic variant of the CFTR gene — F508del, and the father, was a carrier of a rare variant G194R. Our observation illustrates the difficulty of diagnosing cases of cystic fibrosis and identifying carriers of this disease due to the large number of pathogenic variants of the CFTR gene. Professionals should be actively alert to the risk of having a sick child, especially in families with cases of the disease in relatives.
Acknowledgments
The authors express their gratitude to the Chief Physician of the Medical Center “Health Care of Mother and Child” — Elena B. Nikolaeva.
For citation
Kopylova EA, Deryabina SS, Kudryavtseva EV, Lagutina OV, Kovalev VV. The risk of hereditary pathology during in vitro fertilization: A clinical case of the birth of a child with cystic fibrosis. Bulletin of USMU. 2023;(4):27–39. (In Russ.). EDN: https://elibrary.ru/RZYTVZ.
References
Global, Regional, and National Prevalence and Disability-Adjusted Life-Years for Infertility in 195 Countries and Territories, 1990–2017: Results from a Global Burden of Disease Study, 2017 / H. Sun, T.-T. Gong, Y.-T. Jiang [et al.] // Aging. 2019. Vol. 11, Iss. 23. P. 10952–10991. DOI: https://doi.org/10.18632/aging.102497.
Тлиашинова И. А., Садыкова Р. Н., Мингазова Э. Н. Репродуктивные технологии в решении проблем бесплодия населения (часть II) // Ремедиум. 2022. № 4. С. 292–297. DOI: https://doi.org/10.32687/1561-5936-2022-26-4-292-297.
Женское бесплодие : клинические рекомендации / Рос. о-во акушеров-гинекологов ; Рос. ассоц. репродукции человека. М., 2021. 81 с. URL: https://clck.ru/36dphh (дата обращения: 04.10.2023).
A Systematic Review of the Validated Monogenic Causes of Human Male Infertility: 2020 Update and a Discussion of Emerging Gene-Disease Relationships / B. J. Houston, A. Riera-Escamilla, M. J. Wyrwoll [et al.] // Human Reproduction Update. 2021. Vol. 28, Iss. 1. P. 15–29. DOI: https://doi.org/10.1093/humupd/dmab030.
Мутации гена CFTR у мужчин с бесплодием / Е. В. Соловьева, Д. А. Татару, О. Г. Преда [и др.] // Медицинская генетика. 2018. Т. 17, № 5. С. 28–38. EDN: https://elibrary.ru/xpbttn.
A Systematic Review and Evidence Assessment of Monogenic Gene-Disease Relationships in Human Female Infertility and Differences in Sex Development / A. Van Der Kelen, Ö. Okutman, E. Javey [et al.] // Human Reproduction Update. 2023. Vol. 29, Iss. 2. P. 218–232. DOI: https://doi.org/10.1093/humupd/dmac044.
Кондратьева Е. И., Каширская Н. Ю., Рославцева Е. А. Обзор национального консенсуса «Муковисцидоз: определение, диагностические критерии, терапия» для диетологов и гастроэнтерологов // Вопросы детской диетологии. 2018. Т. 16. С. 58–74. EDN: https://elibrary.ru/ywrfoj.
Кистозный фиброз (муковисцидоз) : клинические рекомендации / Союз педиатров России ; Ассоц. мед. генетиков ; Рос. респиратор. о-во [и др.]. М., 2021. 225 с. URL: https://clck.ru/36dqRF (дата обращения: 06.10.2023).
Мужское бесплодие : клинические рекомендации / Рос. о-во урологов. М., 2021. 41 с. URL: https://clck.ru/36dqYn (дата обращения: 06.10.2023).
The Clinical and Functional Translation of CFTR. URL: https://clck.ru/36dqkZ (date of access: 09.10.2023).
CFTR CF transmembrane conductance regulator // Genome Aggregation Database. URL: https://clck.ru/36dqnm (date of access: 09.10.2023).
Роль неонатального скрининга в оптимизации медицинской помощи больным муковисцидозом в РФ / В. Д. Шерман, Н. И. Капранов, Н. Ю. Каширская, Е. И. Кондратьева // Медицинская генетика. 2013. № 11. С. 24–28. EDN: https://elibrary.ru/tjdiel.
Gregg A. R. Expanded Carrier Screening // Obstetrics and Gynecology Clinics of North America. 2018. Vol. 45, Iss. 1. P. 103–112. DOI: https://doi.org/10.1016/j.ogc.2017.10.005.
Singer A., Sagi-Dain L. Impact of a National Genetic Carrier-Screening Program for Reproductive Purposes // Acta Obstetricia et Gynecologica Scandinavica. 2020. Vol. 99, Iss. 6. P. 802–808. DOI: https://doi.org/10.1111/aogs.13858.
ACMG Position Statement on Prenatal/Preconception Expanded Carrier Screening / W. W. Grody, B. H. Thompson, A. R. Gregg [et al.] // Genetics in Medicine. 2013. Vol. 15, Iss. 6. P. 482–483. DOI: https://doi.org/10.1038/gim.2013.47.
Проблемы диагностики муковисцидоза и пути их решения в России / А. А. Баранов, Н. И. Капранов, Н. Ю. Каширская [и др.] // Педиатрическая фармакология. 2014. Т. 11, № 6. С. 16–23. DOI: https://doi.org/10.15690/pf.v11i6.1211.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Copyright © 2023 Kopylova E. A., Deryabina S. S., Kudryavtseva E. V., Lagutina O. V., Kovalev V. V.